Michael Petusky
Stock Analyst at Barrington Research
(2.23)
# 2,696
Out of 5,165 analysts
234
Total ratings
38.5%
Success rate
-2.63%
Average return
Main Sectors:
Stocks Rated by Michael Petusky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFCR Lifecore Biomedical | Upgrades: Outperform | $5.5 | $4.39 | +25.28% | 7 | Mar 17, 2026 | |
| BVS Bioventus | Maintains: Outperform | $13 → $14 | $9.00 | +55.56% | 2 | Mar 6, 2026 | |
| OPK OPKO Health | Maintains: Outperform | $2.25 → $1.5 | $1.18 | +27.12% | 16 | Mar 2, 2026 | |
| XRAY DENTSPLY SIRONA | Maintains: Outperform | $14 → $17 | $11.89 | +43.04% | 28 | Mar 2, 2026 | |
| ANIK Anika Therapeutics | Maintains: Outperform | $16 → $17 | $14.22 | +19.55% | 22 | Feb 27, 2026 | |
| LMAT LeMaitre Vascular | Maintains: Outperform | $95 → $105 | $112.25 | -6.46% | 15 | Feb 26, 2026 | |
| OFIX Orthofix Medical | Maintains: Outperform | $18 → $17 | $11.89 | +42.98% | 6 | Feb 25, 2026 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $106 → $109 | $68.82 | +58.38% | 26 | Feb 25, 2026 | |
| HSIC Henry Schein | Maintains: Outperform | $79 → $97 | $73.84 | +31.37% | 19 | Feb 25, 2026 | |
| USPH U.S. Physical Therapy | Maintains: Outperform | $103 | $76.38 | +34.86% | 27 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $94 | $59.84 | +57.09% | 36 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $38 → $42 | $29.75 | +41.18% | 19 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $1 → $1.5 | $0.87 | +71.98% | 11 | Jan 6, 2026 |
Lifecore Biomedical
Mar 17, 2026
Upgrades: Outperform
Price Target: $5.5
Current: $4.39
Upside: +25.28%
Bioventus
Mar 6, 2026
Maintains: Outperform
Price Target: $13 → $14
Current: $9.00
Upside: +55.56%
OPKO Health
Mar 2, 2026
Maintains: Outperform
Price Target: $2.25 → $1.5
Current: $1.18
Upside: +27.12%
DENTSPLY SIRONA
Mar 2, 2026
Maintains: Outperform
Price Target: $14 → $17
Current: $11.89
Upside: +43.04%
Anika Therapeutics
Feb 27, 2026
Maintains: Outperform
Price Target: $16 → $17
Current: $14.22
Upside: +19.55%
LeMaitre Vascular
Feb 26, 2026
Maintains: Outperform
Price Target: $95 → $105
Current: $112.25
Upside: -6.46%
Orthofix Medical
Feb 25, 2026
Maintains: Outperform
Price Target: $18 → $17
Current: $11.89
Upside: +42.98%
Merit Medical Systems
Feb 25, 2026
Maintains: Outperform
Price Target: $106 → $109
Current: $68.82
Upside: +58.38%
Henry Schein
Feb 25, 2026
Maintains: Outperform
Price Target: $79 → $97
Current: $73.84
Upside: +31.37%
U.S. Physical Therapy
Feb 20, 2026
Maintains: Outperform
Price Target: $103
Current: $76.38
Upside: +34.86%
Feb 6, 2026
Maintains: Outperform
Price Target: $93 → $94
Current: $59.84
Upside: +57.09%
Jan 16, 2026
Maintains: Outperform
Price Target: $38 → $42
Current: $29.75
Upside: +41.18%
Jan 6, 2026
Maintains: Outperform
Price Target: $1 → $1.5
Current: $0.87
Upside: +71.98%